Linder R, Horenkamp-Sonntag D, Engel S, Köppel D, Heilmann T, Verheyen F
WINEG - Wissenschaftliches Institut der TK für Nutzen und Effizienz im Gesundheitswesen, Hamburg.
Fachreferat Disease-Management-Programme der Techniker Krankenkasse, Hamburg.
Dtsch Med Wochenschr. 2014 Jan;139(1-2):19-22. doi: 10.1055/s-0033-1349545. Epub 2013 Sep 23.
The specific documentation for disease management programs (DMP) in Germany with respect to § 137 Social Code Book V is the basis for evaluating the DMP. DMP run up costs of the order of a billion euro without assessing evidence-based benefit so far. Aim of this study was to question if and to which extent this documentation may be suitable for reliable quality assurance in its present form.
Data of nearly 300000 insured persons of a German Statutory Health Insurance (Techniker Krankenkasse, TK) which were continuously registered from July 1st 2009 until December 31st 2010 in a DMP were analyzed. We analyzed how items which were components of claims data and of DMP documentation were matched.
With regard to prescriptions there were some considerable differences. Prescription of glibenclamid was documented twice as frequently in the DMP documentation compared to prescriptions filled in pharmacies. Only a fraction of emergency hospitalizations documented in the claims data were found in the DMP documentation. Investigations of the fundus oculi for diabetics are mentioned three times more frequently in the DMP documentation than they are accounted by ophthalmologists.
There are considerable differences between claims data and DMP specific documentation. The latter shows a plainly reduced validity for investigated fields in the documentation forms. Reasons for this are manifold. Former evaluations of DM Ps carried out just on the basis of DMP documentation are thus highly questionable. Therefore, the DMPs themselves and their documentation have to be reformed.
德国疾病管理项目(DMP)根据《社会法典》第五卷第137条的具体文件是评估DMP的基础。到目前为止,DMP的运营成本高达数十亿欧元,却未评估循证效益。本研究的目的是质疑该文件目前的形式是否以及在多大程度上适合可靠的质量保证。
分析了德国法定健康保险(技术人员健康保险基金,TK)近30万名参保人员的数据,这些人员在2009年7月1日至2010年12月31日期间持续登记参加了一个DMP。我们分析了作为理赔数据组成部分的项目与DMP文件中的项目是如何匹配的。
在处方方面存在一些显著差异。与药房配药记录相比,格列本脲的处方在DMP文件中的记录频率高出一倍。理赔数据中记录的急诊住院病例,在DMP文件中仅发现了一小部分。糖尿病患者眼底检查在DMP文件中的提及频率比眼科医生记录的高出两倍。
理赔数据与DMP特定文件之间存在显著差异。后者在文件表格中所调查领域的有效性明显降低。原因是多方面的。因此,以前仅基于DMP文件对DMP进行的评估很值得怀疑。所以,DMP本身及其文件必须进行改革。